 | • レポートコード：D0804-14410 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、β遮断薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。β遮断薬の種類別市場規模（非選択的エージェント、選択的エージェント）、用途別市場規模（不整脈、高血圧）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Bristol-Myers Squibb、Astra Zeneca、Novartis、Sanofi、Merck、GSK、Eli Lilly、Jhonson and Johnson、Bayer、Teva Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・β遮断薬の北米市場（アメリカ、カナダ、メキシコ） ・β遮断薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・β遮断薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・β遮断薬の南米市場（ブラジル、アルゼンチン） ・β遮断薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：非選択的エージェント、選択的エージェント ・用途別分析：不整脈、高血圧 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global β-blockers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The β-blockers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
β-blockers market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, β-blockers market has been segmented into
Nonselective Agents
Selective Agents
By Application, β-blockers has been segmented into:
Abnormal Heart Rhythms
Hypertension
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global β-blockers market presented in the report. This section sheds light on the sales growth of different regional and country-level β-blockers markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global β-blockers market.
The report offers in-depth assessment of the growth and other aspects of the β-blockers market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and β-blockers Market Share Analysis
β-blockers competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, β-blockers sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the β-blockers sales, revenue and market share for each player covered in this report.
The major players covered in β-blockers are:
Pfizer
Bristol-Myers Squibb
Astra Zeneca
Novartis
Sanofi
Merck
GSK
Eli Lilly
Jhonson and Johnson
Bayer
Teva Pharmaceutical
Among other players domestic and global, β-blockers market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe β-blockers product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of β-blockers, with price, sales, revenue and global market share of β-blockers in 2018 and 2019.
Chapter 3, the β-blockers competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the β-blockers breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, β-blockers market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe β-blockers sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 β-blockers Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global β-blockers Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Nonselective Agents
1.2.3 Selective Agents
1.3 Market Analysis by Application
1.3.1 Overview: Global β-blockers Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Abnormal Heart Rhythms
1.3.3 Hypertension
1.4 Overview of Global β-blockers Market
1.4.1 Global β-blockers Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb
2.2.1 Bristol-Myers Squibb Details
2.2.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol-Myers Squibb SWOT Analysis
2.2.4 Bristol-Myers Squibb Product and Services
2.2.5 Bristol-Myers Squibb β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astra Zeneca
2.3.1 Astra Zeneca Details
2.3.2 Astra Zeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astra Zeneca SWOT Analysis
2.3.4 Astra Zeneca Product and Services
2.3.5 Astra Zeneca β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GSK SWOT Analysis
2.7.4 GSK Product and Services
2.7.5 GSK β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Jhonson and Johnson
2.9.1 Jhonson and Johnson Details
2.9.2 Jhonson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Jhonson and Johnson SWOT Analysis
2.9.4 Jhonson and Johnson Product and Services
2.9.5 Jhonson and Johnson β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bayer SWOT Analysis
2.10.4 Bayer Product and Services
2.10.5 Bayer β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Teva Pharmaceutical
2.11.1 Teva Pharmaceutical Details
2.11.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Teva Pharmaceutical SWOT Analysis
2.11.4 Teva Pharmaceutical Product and Services
2.11.5 Teva Pharmaceutical β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global β-blockers Sales and Market Share by Manufacturer (2018-2019)
3.2 Global β-blockers Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 β-blockers Manufacturer Market Share in 2019
3.3.2 Top 6 β-blockers Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global β-blockers Sales, Revenue and Market Share by Regions
4.1.1 Global β-blockers Sales and Market Share by Regions (2015-2020)
4.1.2 Global β-blockers Revenue and Market Share by Regions (2015-2020)
4.2 North America β-blockers Sales and Growth Rate (2015-2020)
4.3 Europe β-blockers Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific β-blockers Sales and Growth Rate (2015-2020)
4.5 South America β-blockers Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa β-blockers Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America β-blockers Sales, Revenue and Market Share by Country
5.1.1 North America β-blockers Sales and Market Share by Country (2015-2020)
5.1.2 North America β-blockers Revenue and Market Share by Country (2015-2020)
5.2 United States β-blockers Sales and Growth Rate (2015-2020)
5.3 Canada β-blockers Sales and Growth Rate (2015-2020)
5.4 Mexico β-blockers Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe β-blockers Sales, Revenue and Market Share by Country
6.1.1 Europe β-blockers Sales and Market Share by Country (2015-2020)
6.1.2 Europe β-blockers Revenue and Market Share by Country (2015-2020)
6.2 Germany β-blockers Sales and Growth Rate (2015-2020)
6.3 UK β-blockers Sales and Growth Rate (2015-2020)
6.4 France β-blockers Sales and Growth Rate (2015-2020)
6.5 Russia β-blockers Sales and Growth Rate (2015-2020)
6.6 Italy β-blockers Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific β-blockers Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific β-blockers Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific β-blockers Revenue and Market Share by Regions (2015-2020)
7.2 China β-blockers Sales and Growth Rate (2015-2020)
7.3 Japan β-blockers Sales and Growth Rate (2015-2020)
7.4 Korea β-blockers Sales and Growth Rate (2015-2020)
7.5 India β-blockers Sales and Growth Rate (2015-2020)
7.6 Southeast Asia β-blockers Sales and Growth Rate (2015-2020)
7.7 Australia β-blockers Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America β-blockers Sales, Revenue and Market Share by Country
8.1.1 South America β-blockers Sales and Market Share by Country (2015-2020)
8.1.2 South America β-blockers Revenue and Market Share by Country (2015-2020)
8.2 Brazil β-blockers Sales and Growth Rate (2015-2020)
8.3 Argentina β-blockers Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa β-blockers Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa β-blockers Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa β-blockers Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia β-blockers Sales and Growth Rate (2015-2020)
9.3 Turkey β-blockers Sales and Growth Rate (2015-2020)
9.4 Egypt β-blockers Sales and Growth Rate (2015-2020)
9.5 South Africa β-blockers Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global β-blockers Sales and Market Share by Type (2015-2020)
10.2 Global β-blockers Revenue and Market Share by Type (2015-2020)
10.3 Global β-blockers Price by Type (2015-2020)
11 Global β-blockers Market Segment by Application
11.1 Global β-blockers Sales Market Share by Application (2015-2020)
11.2 Global β-blockers Revenue Market Share by Application (2015-2020)
11.3 Global β-blockers Price by Application (2015-2020)
12 Market Forecast
12.1 Global β-blockers Sales, Revenue and Growth Rate (2021-2025)
12.2 β-blockers Market Forecast by Regions (2021-2025)
12.2.1 North America β-blockers Market Forecast (2021-2025)
12.2.2 Europe β-blockers Market Forecast (2021-2025)
12.2.3 Asia-Pacific β-blockers Market Forecast (2021-2025)
12.2.4 South America β-blockers Market Forecast (2021-2025)
12.2.5 Middle East & Africa β-blockers Market Forecast (2021-2025)
12.3 β-blockers Market Forecast by Type (2021-2025)
12.3.1 Global β-blockers Sales Forecast by Type (2021-2025)
12.3.2 Global β-blockers Market Share Forecast by Type (2021-2025)
12.4 β-blockers Market Forecast by Application (2021-2025)
12.4.1 Global β-blockers Sales Forecast by Application (2021-2025)
12.4.2 Global β-blockers Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global β-blockers Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of β-blockers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global β-blockers Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer β-blockers Major Business
Table 9. Pfizer β-blockers Total Revenue (USD Million) (2017-2018)
Table 10. Pfizer SWOT Analysis
Table 11. Pfizer β-blockers Product and Services
Table 12. Pfizer β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 14. Bristol-Myers Squibb β-blockers Major Business
Table 15. Bristol-Myers Squibb β-blockers Total Revenue (USD Million) (2017-2018)
Table 16. Bristol-Myers Squibb SWOT Analysis
Table 17. Bristol-Myers Squibb β-blockers Product and Services
Table 18. Bristol-Myers Squibb β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 20. Astra Zeneca β-blockers Major Business
Table 21. Astra Zeneca β-blockers Total Revenue (USD Million) (2017-2018)
Table 22. Astra Zeneca SWOT Analysis
Table 23. Astra Zeneca β-blockers Product and Services
Table 24. Astra Zeneca β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis Basic Information, Manufacturing Base and Competitors
Table 26. Novartis β-blockers Major Business
Table 27. Novartis β-blockers Total Revenue (USD Million) (2017-2018)
Table 28. Novartis SWOT Analysis
Table 29. Novartis β-blockers Product and Services
Table 30. Novartis β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi β-blockers Major Business
Table 33. Sanofi β-blockers Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi SWOT Analysis
Table 35. Sanofi β-blockers Product and Services
Table 36. Sanofi β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merck Basic Information, Manufacturing Base and Competitors
Table 38. Merck β-blockers Major Business
Table 39. Merck β-blockers Total Revenue (USD Million) (2017-2018)
Table 40. Merck SWOT Analysis
Table 41. Merck β-blockers Product and Services
Table 42. Merck β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GSK Basic Information, Manufacturing Base and Competitors
Table 44. GSK β-blockers Major Business
Table 45. GSK β-blockers Total Revenue (USD Million) (2017-2018)
Table 46. GSK SWOT Analysis
Table 47. GSK β-blockers Product and Services
Table 48. GSK β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 50. Eli Lilly β-blockers Major Business
Table 51. Eli Lilly β-blockers Total Revenue (USD Million) (2017-2018)
Table 52. Eli Lilly SWOT Analysis
Table 53. Eli Lilly β-blockers Product and Services
Table 54. Eli Lilly β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Jhonson and Johnson Basic Information, Manufacturing Base and Competitors
Table 56. Jhonson and Johnson β-blockers Major Business
Table 57. Jhonson and Johnson β-blockers Total Revenue (USD Million) (2017-2018)
Table 58. Jhonson and Johnson SWOT Analysis
Table 59. Jhonson and Johnson β-blockers Product and Services
Table 60. Jhonson and Johnson β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer β-blockers Major Business
Table 63. Bayer β-blockers Total Revenue (USD Million) (2017-2018)
Table 64. Bayer SWOT Analysis
Table 65. Bayer β-blockers Product and Services
Table 66. Bayer β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Teva Pharmaceutical β-blockers Major Business
Table 69. Teva Pharmaceutical β-blockers Total Revenue (USD Million) (2017-2018)
Table 70. Teva Pharmaceutical SWOT Analysis
Table 71. Teva Pharmaceutical β-blockers Product and Services
Table 72. Teva Pharmaceutical β-blockers Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global β-blockers Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global β-blockers Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global β-blockers Sales by Regions (2015-2020) (K Units)
Table 76. Global β-blockers Sales Market Share by Regions (2015-2020)
Table 77. Global β-blockers Revenue by Regions (2015-2020) (USD Million)
Table 78. North America β-blockers Sales by Countries (2015-2020) (K Units)
Table 79. North America β-blockers Sales Market Share by Countries (2015-2020)
Table 80. North America β-blockers Revenue by Countries (2015-2020) (USD Million)
Table 81. North America β-blockers Revenue Market Share by Countries (2015-2020)
Table 82. Europe β-blockers Sales by Countries (2015-2020) (K Units)
Table 83. Europe β-blockers Sales Market Share by Countries (2015-2020)
Table 84. Europe β-blockers Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific β-blockers Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific β-blockers Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific β-blockers Revenue by Regions (2015-2020) (USD Million)
Table 88. South America β-blockers Sales by Countries (2015-2020) (K Units)
Table 89. South America β-blockers Sales Market Share by Countries (2015-2020)
Table 90. South America β-blockers Revenue by Countries (2015-2020) (USD Million)
Table 91. South America β-blockers Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa β-blockers Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa β-blockers Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa β-blockers Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa β-blockers Revenue Market Share by Countries (2015-2020)
Table 96. Global β-blockers Sales by Type (2015-2020) (K Units)
Table 97. Global β-blockers Sales Share by Type (2015-2020)
Table 98. Global β-blockers Revenue by Type (2015-2020) (USD Million)
Table 99. Global β-blockers Revenue Share by Type (2015-2020)
Table 100. Global β-blockers Sales by Application (2015-2020) (K Units)
Table 101. Global β-blockers Sales Share by Application (2015-2020)
Table 102. Global β-blockers Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global β-blockers Market Share Forecast by Regions (2021-2025)
Table 104. Global β-blockers Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global β-blockers Market Share Forecast by Type (2021-2025)
Table 106. Global β-blockers Sales Forecast by Application (2021-2025)
Table 107. Global β-blockers Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. β-blockers Picture
Figure 2. Global Sales Market Share of β-blockers by Type in 2019
Figure 3. Nonselective Agents Picture
Figure 4. Selective Agents Picture
Figure 5. β-blockers Sales Market Share by Application in 2018
Figure 6. Abnormal Heart Rhythms Picture
Figure 7. Hypertension Picture
Figure 8. Global β-blockers Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia β-blockers Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey β-blockers Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global β-blockers Sales Market Share by Manufacturer in 2019
Figure 29. Global β-blockers Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 β-blockers Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 β-blockers Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global β-blockers Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global β-blockers Revenue Market Share by Regions (2015-2020)
Figure 36. Global β-blockers Revenue Market Share by Regions in 2018
Figure 37. North America β-blockers Sales and Growth Rate (2015-2020)
Figure 38. Europe β-blockers Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific β-blockers Sales and Growth Rate (2015-2020)
Figure 40. South America β-blockers Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa β-blockers Sales and Growth Rate (2015-2020)
Figure 42. North America β-blockers Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America β-blockers Sales Market Share by Countries (2015-2020)
Figure 44. North America β-blockers Sales Market Share by Countries in 2018
Figure 45. North America β-blockers Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America β-blockers Revenue Market Share by Countries in 2018
Figure 47. United States β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe β-blockers Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe β-blockers Revenue Market Share by Countries (2015-2020)
Figure 52. Europe β-blockers Revenue Market Share by Countries in 2019
Figure 53. Germany β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific β-blockers Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific β-blockers Sales Market Share by Regions 2019
Figure 60. Asia-Pacific β-blockers Revenue Market Share by Regions 2019
Figure 61. China β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America β-blockers Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America β-blockers Sales Market Share by Countries in 2019
Figure 68. South America β-blockers Revenue Market Share by Countries in 2019
Figure 69. Brazil β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa β-blockers Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa β-blockers Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa β-blockers Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa β-blockers Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa β-blockers Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global β-blockers Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global β-blockers Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales β-blockers Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales β-blockers Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales β-blockers Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales β-blockers Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales β-blockers Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
アルファブロッカーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Alpha Blockers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alpha Blockers market report p…- 広告ブロッカーの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Advertisement Blockers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Advertisement Blockers…
- アンジオテンシン受容体遮断薬（ARB）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Angiotensin Receptor Blockers (ARBs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Angioten…
- 慢性腎臓病（CKD）治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chronic Kidney Disease (CKD) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chronic Ki…
- 狭心症の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Angina market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 12300 million by 2025, from USD 10550 million in 2019. The Angina market report provides a…